What Researchers Did
Researchers conducted a retrospective observational study in Japan to see if inhaling hydrogen gas could protect cancer patients' bone marrow from damage caused by intensity-modulated radiation therapy (IMRT).
What They Found
The study found that while IMRT alone significantly reduced white blood cells and platelets, daily 30-minute inhalation of 5% hydrogen gas significantly lessened these reductions (P = 0.0011 for white blood cells, P = 0.0275 for platelets). This protective effect occurred without affecting red blood cells, hemoglobin, hematocrit, or the tumor's response to radiation.
What This Means for Canadian Patients
For Canadian cancer patients undergoing radiation therapy, this research suggests a potential way to protect their bone marrow, which is vital for maintaining healthy blood counts. Preserving white blood cells and platelets can help reduce risks of infection and bleeding during treatment, potentially improving patient well-being and treatment tolerance.
Canadian Relevance
While this study was not conducted in Canada, it explores mitigating radiation-induced damage, which is related to delayed radiation injury, a Health Canada-recognized indication for hyperbaric oxygen therapy.
Study Limitations
This was a retrospective observational study conducted at a single clinic with a small number of participants, limiting the generalizability of the findings.